
This study focused on the expression of cancer-testis antigens (CTAs) in non-small cell lung cancer (NSCLC) and their relationship with immune cells in the tumor microenvironment. The researchers identified a specific pattern of immune cell infiltration associated with CTAs. They selected eight CTAs for further analysis and found that most NSCLC cases expressed at least one of these CTAs. The expression of certain CTAs correlated with specific immune cell types, such as M2 macrophages, regulatory T cells, and plasma cells. However, no significant correlations were observed between CTAs and clinical outcomes. The study suggests that CTAs could be potential targets for immunotherapy based on their association with immune cells and possible in-situ immunogenic effects.
Like
Save
Share